Tilray Brands Inc
NASDAQ:TLRY

Watchlist Manager
Tilray Brands Inc Logo
Tilray Brands Inc
NASDAQ:TLRY
Watchlist
Price: 0.40245 USD 3.19%
Market Cap: 412.7m USD

Relative Value

The Relative Value of one TLRY stock under the Base Case scenario is 1.54428 USD. Compared to the current market price of 0.40245 USD, Tilray Brands Inc is Undervalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TLRY Relative Value
Base Case
1.54428 USD
Undervaluation 74%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
75
Median 3Y
2.1
Median 5Y
2.9
Industry
2.5
Forward
0.4
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-3.5
Industry
21.3
Forward
-0.4
vs History
vs Industry
14
Median 3Y
-19.6
Median 5Y
-19.6
Industry
16.7
vs History
vs Industry
7
Median 3Y
-8.5
Median 5Y
-10.1
Industry
24.7
vs History
98
vs Industry
80
Median 3Y
0.4
Median 5Y
0.5
Industry
2.1
vs History
98
vs Industry
74
Median 3Y
2.2
Median 5Y
3.1
Industry
2.6
Forward
0.5
vs History
85
vs Industry
61
Median 3Y
9.7
Median 5Y
11.1
Industry
5.1
vs History
15
vs Industry
38
Median 3Y
-6.3
Median 5Y
-12.6
Industry
12.8
Forward
7.6
vs History
vs Industry
20
Median 3Y
-7.3
Median 5Y
-9
Industry
16.3
Forward
-0.9
vs History
vs Industry
15
Median 3Y
-19.1
Median 5Y
-21.1
Industry
14.9
vs History
vs Industry
8
Median 3Y
-18.3
Median 5Y
-16.7
Industry
18.2
vs History
98
vs Industry
83
Median 3Y
0.4
Median 5Y
0.5
Industry
1.9

Multiples Across Competitors

TLRY Competitors Multiples
Tilray Brands Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Tilray Brands Inc
NASDAQ:TLRY
385.1m USD 0.5 -0.4 18.3 -4.2
US
Eli Lilly and Co
NYSE:LLY
729.5B USD 14.9 65.6 35.3 38.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
372.9B USD 4.2 17.1 12.5 16.4
DK
Novo Nordisk A/S
CSE:NOVO B
2.2T DKK 7.2 20.7 14.3 16.4
CH
Roche Holding AG
SIX:ROG
213.6B CHF 3.5 25.7 9.7 11.3
CH
Novartis AG
SIX:NOVN
190.9B CHF 4.4 18 10.7 14.3
UK
AstraZeneca PLC
LSE:AZN
166.5B GBP 4.1 29.1 131.1 197.7
US
Merck & Co Inc
NYSE:MRK
198.5B USD 3.1 11.4 8.5 10.3
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
133.4B USD 2.1 16.9 7.3 10.3
P/E Multiple
Earnings Growth PEG
US
Tilray Brands Inc
NASDAQ:TLRY
Average P/E: 25.6
Negative Multiple: -0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
65.6
50%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.1
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
20.7
18%
1.2
CH
Roche Holding AG
SIX:ROG
25.7
32%
0.8
CH
Novartis AG
SIX:NOVN
18
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
29.1
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.4
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
16.9
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Tilray Brands Inc
NASDAQ:TLRY
Average EV/EBITDA: 395.9
18.3
51%
0.4
US
Eli Lilly and Co
NYSE:LLY
35.3
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.5
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
14.3
13%
1.1
CH
Roche Holding AG
SIX:ROG
9.7
5%
1.9
CH
Novartis AG
SIX:NOVN
10.7
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
131.1
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.5
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.3
2%
3.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Tilray Brands Inc
NASDAQ:TLRY
Average EV/EBIT: 1 867.3
Negative Multiple: -4.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.6
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.4
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
16.4
14%
1.2
CH
Roche Holding AG
SIX:ROG
11.3
6%
1.9
CH
Novartis AG
SIX:NOVN
14.3
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197.7
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.3
11%
0.9
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
10%
1